By Nancy Lapid April 16 (Reuters) - Eli Lilly's GLP-1 drug tirzepatide yields greater weight loss on average than Novo ...

As weight‑loss drugs surge in popularity, a study raises a new question about what patients may be losing along the way.

A large-scale, 5-year clinical trial from the Generation 100 study in Norway has found that high-intensity interval training ...

All 4 T1D participants receiving SAB-142 showed C-peptide preservation with 3 of the 4 participants showing a super responder ...

AI reasoning does not necessarily require spending huge amounts on frontier models. Instead, smaller models can yield ...

Search engines now rely on AI-driven systems that continuously evaluate authority, freshness, and first-party signals to ...

A new study suggests that Eli Lilly’s GLP-1 drug tirzepatide, marketed as Zepbound and Mounjaro, leads to greater overall ...

Residents across central Florida woke this week to hazy skies and an urgent warning from air-quality officials: stay inside, ...

On Tuesday, April 21, a special broadcast celebrating the Version 1.2 update for The Seven Deadly Sins: Origin was held on ...

Kristopher Blume details why smart building features, thermal imaging, drones and breathable-air redundancy concepts are ...

More than a year after a Russian drone slammed into the massive steel arch covering Chernobyl’s destroyed Reactor 4, the ...

Britain stands at an inflexion point in its approach to asylum and immigration policy. The current discourse, dominated by ...